AGN-214868

DRUG3 trials

Sponsors

Allergan

Conditions

Neuralgia, PostherpeticUrinary Bladder, Overactive

Phase 2

A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

CompletedNCT01129531

AllerganNeuralgia, Postherpetic

Start: 2010-06-30End: 2012-01-31Updated: 2013-11-15

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

CompletedNCT01157377

AllerganUrinary Bladder, Overactive

Start: 2010-10-31End: 2013-05-31Updated: 2014-03-19

A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

TerminatedNCT01678924

AllerganNeuralgia, Postherpetic

Start: 2013-01-31End: 2015-09-30Updated: 2020-01-07